$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000072312513000108 Filed on July 08, 2013

Income Statement

Concept	2013 Q3	2013 Q2	2012 Q3
Revenue	$2.843B	$2.318B	$1.963B
YoY Change	44.83%	6.72%	-8.27%
Cost Of Revenue	$2.135B	$1.762B	$1.744B
YoY Change	22.42%	-9.08%	-4.12%
Gross Profit	$708.0M	$556.0M	$219.0M
YoY Change	223.29%	137.61%	-31.78%
Gross Profit Margin	24.9%	23.99%	11.16%
Selling, General & Admin	$194.0M	$127.0M	$139.0M
YoY Change	39.57%	-18.59%	-10.32%
% of Gross Profit	27.4%	22.84%	63.47%
Research & Development	$267.0M	$226.0M	$235.0M
YoY Change	13.62%	-2.16%	12.44%
% of Gross Profit	37.71%	40.65%	107.31%
Depreciation & Amortization	$450.0M	$421.0M	$483.0M
YoY Change	-6.83%	-16.14%	-12.97%
% of Gross Profit	63.56%	75.72%	220.55%
Operating Expenses	$462.0M	$353.0M	$374.0M
YoY Change	23.53%	-8.79%	3.31%
Operating Profit	$207.0M	$149.0M	-$149.0M
YoY Change	-238.93%	-179.26%	192.16%
Interest Expense	-$60.00M	$54.00M	-$48.00M
YoY Change	25.0%	-3.57%	860.0%
% of Operating Profit	-28.99%	36.24%
Other Income/Expense, Net	-$1.000M	-$45.00M	$1.000M
YoY Change	-200.0%	2150.0%	-100.91%
Pretax Income	$1.678B	$52.00M	-$196.0M
YoY Change	-956.12%	-121.4%	151.28%
Income Tax	$5.000M	-$1.000M	$14.00M
% Of Pretax Income	0.3%	-1.92%
Net Earnings	$1.708B	$43.00M	-$243.0M
YoY Change	-802.88%	-113.44%	80.0%
Net Earnings / Revenue	60.08%	1.86%	-12.38%
Basic Earnings Per Share	$1.65	$0.04	-$0.24
Diluted Earnings Per Share	$1.51	$0.04	-$0.24
COMMON SHARES
Basic Shares Outstanding	1.038B shares	1.024B shares	1.018B shares
Diluted Shares Outstanding		1.047B shares

Balance Sheet

Concept	2013 Q3	2013 Q2	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.101B	$2.552B	$2.559B
YoY Change	21.18%	9.76%	18.47%
Cash & Equivalents	$2.880B	$2.440B	$2.459B
Short-Term Investments	$221.0M	$112.0M	$100.0M
Other Short-Term Assets	$276.0M	$99.00M	$98.00M
YoY Change	181.63%	26.92%	3.16%
Inventory	$2.649B	$1.732B	$1.812B
Prepaid Expenses
Receivables	$2.069B	$1.250B	$933.0M
Other Receivables	$260.0M	$253.0M	$356.0M
Total Short-Term Assets	$8.911B	$5.886B	$5.758B
YoY Change	54.76%	4.55%	-1.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.626B	$6.830B	$7.103B
YoY Change	7.36%	-4.58%	-5.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$396.0M	$272.0M	$389.0M
YoY Change	1.8%	-32.51%	-19.46%
Other Assets	$439.0M	$389.0M	$286.0M
YoY Change	53.5%	2.91%	-31.25%
Total Long-Term Assets	$10.21B	$8.169B	$8.570B
YoY Change	19.1%	-5.95%	-3.92%
TOTAL ASSETS
Total Short-Term Assets	$8.911B	$5.886B	$5.758B
Total Long-Term Assets	$10.21B	$8.169B	$8.570B
Total Assets	$19.12B	$14.06B	$14.33B
YoY Change	33.43%	-1.82%	-2.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.048B	$736.0M	$818.0M
YoY Change	28.12%	-5.52%	-31.09%
Accrued Expenses	$267.0M	$216.0M	$290.0M
YoY Change	-7.93%	-53.04%	-37.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.585B	$357.0M	$224.0M
YoY Change	607.59%	36.26%	60.0%
Total Short-Term Liabilities	$4.125B	$2.342B	$2.243B
YoY Change	83.91%	7.58%	-9.56%
LONG-TERM LIABILITIES
Long-Term Debt	$4.452B	$3.267B	$3.038B
YoY Change	46.54%	11.27%	63.25%
Other Long-Term Liabilities	$535.0M	$420.0M	$630.0M
YoY Change	-15.08%	-41.42%	12.7%
Total Long-Term Liabilities	$535.0M	$3.687B	$3.668B
YoY Change	-85.41%	0.93%	51.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.125B	$2.342B	$2.243B
Total Long-Term Liabilities	$535.0M	$3.687B	$3.668B
Total Liabilities	$9.112B	$6.029B	$5.911B
YoY Change	54.15%	3.41%	20.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$212.0M	-$1.920B	-$1.402B
YoY Change	-84.88%	65.66%	278.92%
Common Stock	$9.291B	$9.179B	$9.022B
YoY Change	2.98%	3.25%	3.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.142B	$7.328B	$7.700B
YoY Change
Total Liabilities & Shareholders Equity	$19.12B	$14.06B	$14.33B
YoY Change	33.43%	-1.82%	-2.87%

Cashflow Statement

Concept	2013 Q3	2013 Q2	2012 Q3
OPERATING ACTIVITIES
Net Income	$1.708B	$43.00M	-$243.0M
YoY Change	-802.88%	-113.44%	80.0%
Depreciation, Depletion And Amortization	$450.0M	$421.0M	$483.0M
YoY Change	-6.83%	-16.14%	-12.97%
Cash From Operating Activities	$717.0M	$624.0M	$450.0M
YoY Change	59.33%	-9.04%	27.12%
INVESTING ACTIVITIES
Capital Expenditures	-$478.0M	-$203.0M	-$332.0M
YoY Change	43.98%	-26.98%	-61.75%
Acquisitions
YoY Change
Other Investing Activities	-$262.0M	$32.00M	$0.00
YoY Change		-106.17%	-100.0%
Cash From Investing Activities	-$740.0M	-$171.0M	-$332.0M
YoY Change	122.89%	-78.54%	-59.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	463.0M	-74.00M	150.0M
YoY Change	208.67%	-135.58%	-37.5%
NET CHANGE
Cash From Operating Activities	717.0M	624.0M	450.0M
Cash From Investing Activities	-740.0M	-171.0M	-332.0M
Cash From Financing Activities	463.0M	-74.00M	150.0M
Net Change In Cash	440.0M	379.0M	268.0M
YoY Change	64.18%	290.72%	-214.04%
FREE CASH FLOW
Cash From Operating Activities	$717.0M	$624.0M	$450.0M
Capital Expenditures	-$478.0M	-$203.0M	-$332.0M
Free Cash Flow	$1.195B	$827.0M	$782.0M
YoY Change	52.81%	-14.21%	-36.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1590000000	USD
CY2012Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1641000000	USD
CY2013Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	213000000	USD
CY2012Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	237000000	USD
CY2013Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	228000000	USD
CY2012Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	130000000	USD
CY2013Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	736000000	USD
CY2012Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	818000000	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1250000000	USD
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	933000000	USD
CY2013Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	56000000	USD
CY2012Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	63000000	USD
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13281000000	USD
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13722000000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	69000000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	80000000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9076000000	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8920000000	USD
CY2012Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000	USD
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	55000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	86000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67000000	USD
CY2012Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23000000	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21000000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	379700000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	373800000	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	185400000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	379700000	shares
CY2012Q3	us-gaap	Assets Assets	14328000000	USD
CY2013Q2	us-gaap	Assets Assets	14055000000	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	5758000000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	5886000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2693000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2563000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	112000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	100000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	2553000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	198000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	198000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	2018000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	2018000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2554000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	2694000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	346000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	0	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	2563000000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	34000000	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	18000000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	59000000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	481000000	USD
CY2013Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	347000000	USD
CY2012Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	374000000	USD
CY2013Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1000000	USD
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1000000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	643000000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	387000000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2459000000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2440000000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2191000000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2160000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	31000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-19000000	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1034700000	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1017700000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1034700000	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1017700000	shares
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	102000000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	103000000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-308000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-841000000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-529000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-5000000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-5000000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-846000000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-313000000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	34000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-526000000	USD
CY2012Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1938000000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5091000000	USD
CY2013Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1762000000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5522000000	USD
CY2013Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	166000000	USD
CY2012Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	141000000	USD
CY2012Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	248000000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	223000000	USD
CY2013Q2	us-gaap	Depreciation Depreciation	421000000	USD
CY2012Q2	us-gaap	Depreciation Depreciation	502000000	USD
	us-gaap	Depreciation Depreciation	1591000000	USD
	us-gaap	Depreciation Depreciation	1292000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1658000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1354000000	USD
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	2000000	USD
	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	6000000	USD
CY2012Q2	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	2000000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	-224000000	USD
	us-gaap	Derivative Instruments Gain Loss Recognized In Income Net DerivativeInstrumentsGainLossRecognizedInIncomeNet	-29000000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	216000000	USD
CY2012Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	290000000	USD
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	164000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M
CY2012Q3	us-gaap	Equity Method Investments EquityMethodInvestments	389000000	USD
CY2013Q2	us-gaap	Equity Method Investments EquityMethodInvestments	272000000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	332000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	377000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	83000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	41000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	52000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	60000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	77000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	708000000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	703000000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	331000000	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	371000000	USD
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">third</font><font style="font-family:inherit;font-size:10pt;"> quarters of fiscal 2013 and 2012 ended on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 30, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">May 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div></div>
CY2013Q2	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	3000000	USD
CY2012Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14000000	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-45000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-231000000	USD
	us-gaap	Gain Loss On Disposition Of Property GainLossOnDispositionOfProperty	10000000	USD
	us-gaap	Gain Loss On Disposition Of Property GainLossOnDispositionOfProperty	-10000000	USD
CY2012Q2	us-gaap	Gain Loss On Disposition Of Property GainLossOnDispositionOfProperty	-4000000	USD
CY2013Q2	us-gaap	Gain Loss On Disposition Of Property GainLossOnDispositionOfProperty	-5000000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1000000	USD
CY2012Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2013Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1000000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	39000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-31000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	556000000	USD
	us-gaap	Gross Profit GrossProfit	1139000000	USD
	us-gaap	Gross Profit GrossProfit	749000000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	234000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-558000000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-243000000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	52000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-393000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-120000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-262000000	USD
CY2012Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-115000000	USD
CY2013Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-38000000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000000	USD
	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	72000000	USD
CY2013Q2	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	25000000	USD
	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.07
CY2013Q2	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.02
CY2013Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	51000000	USD
CY2012Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	80000000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	296000000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-95000000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-61000000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-22000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-182000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38000000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-101000000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	42000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	79000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	42000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	280000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-134000000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	54000000	USD
	us-gaap	Interest Expense InterestExpense	126000000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are engaged in litigation with Rambus, Inc. ("Rambus") relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus are pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy. On August 28, 2000, we filed a complaint against Rambus in the U.S. District Court for the District of Delaware seeking declaratory and injunctive relief. The complaint alleges, among other things, various anticompetitive activities and also seeks a declaratory judgment that certain Rambus patents are invalid and/or unenforceable. Rambus subsequently filed an answer and counterclaim in Delaware alleging, among other things, infringement of twelve Rambus patents and seeking monetary damages and injunctive relief. We subsequently added claims and defenses based on Rambus' alleged spoliation of evidence and litigation misconduct. The spoliation and litigation misconduct claims and defenses were heard in a bench trial before Judge Robinson in October 2007. On January 9, 2009, Judge Robinson entered an opinion in our favor holding that Rambus had engaged in spoliation and that the twelve Rambus patents in the suit were unenforceable against us. Rambus subsequently appealed the decision to the U.S. Court of Appeals for the Federal Circuit. On May 13, 2011, the Federal Circuit affirmed Judge Robinson's finding of spoliation, but vacated the dismissal sanction and remanded the case to the Delaware District Court for analysis of the remedy based on the Federal Circuit's decision. On January 2, 2013, Judge Robinson entered a new opinion in our favor holding that Rambus had engaged in spoliation, that Rambus' spoliation was done in bad faith, that the spoliation prejudiced us, and that the appropriate sanction was to declare the twelve Rambus patents in the suit unenforceable against us.  On March 27, 2013, Rambus filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. On January 13, 2006, Rambus filed a lawsuit against us in the U.S. District Court for the Northern District of California alleging that certain of our DDR2, DDR3, RLDRAM and RLDRAM II products infringe as many as fourteen Rambus patents and seeking monetary damages, treble damages, and injunctive relief. The Northern District of California Court stayed the trial of the patent phase of the Northern District of California case upon appeal of the Delaware spoliation issue to the Federal Circuit.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants. The complaint alleges that certain of our DRAM and image sensor products infringe two U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 9, 2011, Advanced Data Access LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Tyler) against us and seven other defendants. On November 16, 2011, Advanced Data Access filed an amended complaint. The amended complaint alleged that certain of our DRAM products infringed two U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 14, 2011, Smart Memory Solutions LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and Winbond Electronics Corporation of America.  The complaint alleged that certain of our NOR Flash products infringed a single U.S. patent and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2011, the Board of Trustees for the University of Illinois filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The District Court has stayed the litigation pending the outcome of the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent Office.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 26, 2012, Semiconductor Technologies, LLC filed a patent infringement action in the U.S. District Court for the Eastern District of Texas (Marshall) against us. The complaint alleged that certain of our DRAM products infringed five U.S. patents and sought injunctive relief, damages, attorneys' fees, and costs. On March 20, 2013, we executed a settlement agreement resolving this litigation. The settlement amount did not have a material effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our SDRAM, DDR, DDR2, DDR3, RLDRAM, NAND Flash, NOR Flash and image sensor products, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss, except as noted in the discussion of the Advanced Data Access LLC, Smart Memory Solutions LLC and Semiconductor Technologies, LLC matters above. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 5, 2004, Rambus filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips.  Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases have been removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July, 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We had paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three putative class action lawsuits alleging price-fixing of DRAM products also have been filed against us in Quebec, Ontario, and British Columbia, Canada, on behalf of direct and indirect purchasers, asserting violations of the Canadian Competition Act and other common law claims (collectively the "Canadian Cases").  The claims were initiated between December 2004 (British Columbia) and June 2006 (Quebec). The plaintiffs seek monetary damages, restitution, costs, and attorneys' fees. The substantive allegations in these cases are similar to those asserted in the DRAM antitrust cases filed in the United States.  Plaintiffs' motion for class certification was denied in the British Columbia and Quebec cases in May and June 2008, respectively.  Plaintiffs subsequently filed an appeal of each of those decisions.  On November 12, 2009, the British Columbia Court of Appeal reversed, and on November 16, 2011, the Quebec Court of Appeal also reversed the denial of class certification and remanded the cases for further proceedings. On October 16, 2012, we entered into a settlement agreement resolving these three putative class action cases subject to certain conditions including final court approval of the settlement. The settlement amount did not have a material effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the U.S. indirect purchaser cases and the Canadian Cases above. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Commercial Matters</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against us and Micron Semiconductor B.V., our Netherlands subsidiary, in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between us and Qimonda signed in fall 2008 pursuant to which we purchased all of Qimonda's shares of Inotera Memories, Inc. and seeks an order requiring us to retransfer the Inotera shares purchased from Qimonda to the Qimonda estate. The complaint also seeks to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross license between us and Qimonda entered into at the same time as the share purchase agreement. A three-judge panel will render a decision after a series of hearings with pleadings, arguments and witnesses. Hearings were held on September 25, 2012, February 5, 2013, June 11, 2013 and July 2, 2013. An additional hearing is scheduled for October 8, 2013. We are unable to predict the outcome of this lawsuit and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages and the termination of the patent cross license, which could have a material adverse effect on our business, results of operation or financial condition. As of May 30, 2013, the Inotera shares purchased from Qimonda had a carrying value of $143 million.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the Sponsor Agreement, we have provided payment guarantees related to financing of capital expenditures. (See "Pending Acquisition of Elpida Memory, Inc." note.)</font></div></div>
CY2013Q2	us-gaap	Minority Interest MinorityInterest	698000000	USD
CY2012Q3	us-gaap	Minority Interest MinorityInterest	717000000	USD
	us-gaap	Interest Expense InterestExpense	167000000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	56000000	USD
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	453000000	USD
CY2012Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	512000000	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	1732000000	USD
CY2012Q3	us-gaap	Inventory Net InventoryNet	1812000000	USD
CY2012Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	152000000	USD
CY2013Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	110000000	USD
CY2013Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1169000000	USD
CY2012Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1148000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	6029000000	USD
CY2012Q3	us-gaap	Liabilities Liabilities	5911000000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14328000000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14055000000	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2243000000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2342000000	USD
CY2013Q2	us-gaap	Long Term Debt LongTermDebt	3624000000	USD
CY2012Q3	us-gaap	Long Term Debt LongTermDebt	3262000000	USD
CY2012Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	224000000	USD
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	357000000	USD
CY2012Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3038000000	USD
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3267000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	33000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	387000000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	466000000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	USD
	us-gaap	Minority Interest Increase From Stock Issuance MinorityInterestIncreaseFromStockIssuance	151000000	USD
	us-gaap	Minority Interest Increase From Stock Issuance MinorityInterestIncreaseFromStockIssuance	11000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	57000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	347000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1980000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1170000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1094000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1664000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-789000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-518000000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	43000000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-320000000	USD
CY2012Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-463000000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-188000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	29000000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	149000000	USD
CY2012Q3	us-gaap	Other Assets Current OtherAssetsCurrent	98000000	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	99000000	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	333000000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	389000000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-31000000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-17000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-2000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-9000000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-1000000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10000000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9000000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-57000000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2000000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1000000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2000000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	34000000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	420000000	USD
CY2012Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	630000000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-45000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24000000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-263000000	USD
CY2013Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	17000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-37000000	USD
CY2012Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-30000000	USD
CY2013Q2	us-gaap	Other Receivables OtherReceivables	146000000	USD
CY2012Q3	us-gaap	Other Receivables OtherReceivables	213000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	31000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	54000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	33000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	387000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	499000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	574000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	180000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1367000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	964000000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	466000000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2012Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	1289000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	152000000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation, including restructure and asset impairment activities prior to the third quarter of 2013 that were previously reported in other operating (income) expense, net. In the second quarter of 2013, we reclassified gains and losses from changes in currency exchange rates in order to improve comparability with our industry peers. As a result of the reclassification, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$59 million</font><font style="font-family:inherit;font-size:10pt;"> of losses for the first quarter of 2013 and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14 million</font><font style="font-family:inherit;font-size:10pt;"> of losses for the third quarter and first nine months of 2012, respectively, were reclassified from the amounts previously reported in other operating (income) expense, net to other non-operating income (expense), net. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1065000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	812000000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	11000000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	151000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	11000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-33000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	592000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	63000000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	51000000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23000000	USD
	us-gaap	Profit Loss ProfitLoss	-516000000	USD
	us-gaap	Profit Loss ProfitLoss	-789000000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	43000000	USD
CY2012Q2	us-gaap	Profit Loss ProfitLoss	-320000000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20825000000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20111000000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6830000000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7103000000	USD
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1503000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	664000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	664000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	683000000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	226000000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	231000000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7000000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	93000000	USD
CY2013Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	55000000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	11000000	USD
CY2012Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	5000000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	94000000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1920000000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1402000000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	106000000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	403000000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	2318000000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	6271000000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	2172000000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	6230000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1017900000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1024000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.43
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	481000000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	369000000	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	156000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	71000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	61000000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	21000000	USD
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	21000000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.21
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.82
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.97
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	13200000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.010	pure
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.61	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.60	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.66	pure
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.55	pure
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	169900000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	75700000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	800000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21200000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	17600000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.66
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.29
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.79
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y9M
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	7328000000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	7700000000	USD
CY2012Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8417000000	USD
CY2013Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8026000000	USD
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8486000000	USD
CY2011Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9852000000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	-157000000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	-182000000	USD
CY2012Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	25000000	USD
CY2013Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	31000000	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	22600000	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1017900000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1046600000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	987300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	983900000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	987300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	983900000	shares
CY2013Q2	mu	Available For Sale Securities Debt Maturities After Four Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsAmortizedCost	16000000	USD
CY2013Q2	mu	Available For Sale Securities Debt Maturities After Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsFairValue	16000000	USD
CY2013Q2	mu	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	140000000	USD
CY2013Q2	mu	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	141000000	USD
CY2013Q2	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsAmortizedCost	181000000	USD
CY2013Q2	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsFairValue	181000000	USD
CY2012Q3	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	130000000	USD
CY2013Q2	mu	Equipment Purchase Contracts EquipmentPurchaseContracts	172000000	USD
	mu	Option Indexed To Issuers Equity Cash Paid OptionIndexedToIssuersEquityCashPaid	102000000	USD
	mu	Option Indexed To Issuers Equity Cash Paid OptionIndexedToIssuersEquityCashPaid	48000000	USD
	mu	Option Indexed To Issuers Equity Settlement Cash Received OptionIndexedToIssuersEquitySettlementCashReceived	0	USD
	mu	Option Indexed To Issuers Equity Settlement Cash Received OptionIndexedToIssuersEquitySettlementCashReceived	24000000	USD
	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	0	USD
	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	-1000000	USD
CY2012Q2	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	-1000000	USD
CY2013Q2	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	1000000	USD
CY2012Q2	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	-26000000	USD
	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	-27000000	USD
CY2013Q2	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	6000000	USD
	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	7000000	USD
	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	48000000	USD
	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	216000000	USD
	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	132000000	USD
	mu	Payments On Equipment Purchase Contracts PaymentsOnEquipmentPurchaseContracts	162000000	USD
	mu	Proceeds For Derivative And Hedge Investing Activities ProceedsForDerivativeAndHedgeInvestingActivities	23000000	USD
	mu	Proceeds For Derivative And Hedge Investing Activities ProceedsForDerivativeAndHedgeInvestingActivities	31000000	USD
CY2013Q2	mu	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Subject To Outstanding Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesSubjectToOutstandingAwards	94200000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-29
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-05-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1038475112	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC

Files In Submission

Name	View Source	Status
0000723125-13-000108-index-headers.html	Edgar Link	pending
0000723125-13-000108-index.html	Edgar Link	pending
0000723125-13-000108.txt	Edgar Link	pending
0000723125-13-000108-xbrl.zip	Edgar Link	pending
a2013q3.htm	Edgar Link	pending
a2013q3ex10-107.htm	Edgar Link	pending
a2013q3ex10-131.htm	Edgar Link	pending
a2013q3ex10-132.htm	Edgar Link	pending
a2013q3ex10-133.htm	Edgar Link	pending
a2013q3ex10-134.htm	Edgar Link	pending
a2013q3ex10-135.htm	Edgar Link	pending
a2013q3ex10-136.htm	Edgar Link	pending
a2013q3ex10-137.htm	Edgar Link	pending
a2013q3ex10-138.htm	Edgar Link	pending
a2013q3ex31-1ceocert.htm	Edgar Link	pending
a2013q3ex31-2cfocert.htm	Edgar Link	pending
a2013q3ex32-1906ceocert.htm	Edgar Link	pending
a2013q3ex32-2906cfocert.htm	Edgar Link	pending
deutschebanklogo.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
goldmansachslogo.jpg	Edgar Link	pending
mu-20130530.xml	Edgar Link	completed
mu-20130530.xsd	Edgar Link	pending
mu-20130530_cal.xml	Edgar Link	unprocessable
mu-20130530_def.xml	Edgar Link	unprocessable
mu-20130530_lab.xml	Edgar Link	unprocessable
mu-20130530_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R57.htm	Edgar Link	pending
R57.xml	Edgar Link	unprocessable
R58.htm	Edgar Link	pending
R58.xml	Edgar Link	unprocessable
R59.htm	Edgar Link	pending
R59.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R60.htm	Edgar Link	pending
R60.xml	Edgar Link	unprocessable
R61.htm	Edgar Link	pending
R61.xml	Edgar Link	unprocessable
R62.htm	Edgar Link	pending
R62.xml	Edgar Link	unprocessable
R63.htm	Edgar Link	pending
R63.xml	Edgar Link	unprocessable
R64.htm	Edgar Link	pending
R64.xml	Edgar Link	unprocessable
R65.htm	Edgar Link	pending
R65.xml	Edgar Link	unprocessable
R66.htm	Edgar Link	pending
R66.xml	Edgar Link	unprocessable
R67.htm	Edgar Link	pending
R67.xml	Edgar Link	unprocessable
R68.htm	Edgar Link	pending
R68.xml	Edgar Link	unprocessable
R69.htm	Edgar Link	pending
R69.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R70.htm	Edgar Link	pending
R70.xml	Edgar Link	unprocessable
R71.htm	Edgar Link	pending
R71.xml	Edgar Link	unprocessable
R72.htm	Edgar Link	pending
R72.xml	Edgar Link	unprocessable
R73.htm	Edgar Link	pending
R73.xml	Edgar Link	unprocessable
R74.htm	Edgar Link	pending
R74.xml	Edgar Link	unprocessable
R75.htm	Edgar Link	pending
R75.xml	Edgar Link	unprocessable
R76.htm	Edgar Link	pending
R76.xml	Edgar Link	unprocessable
R77.htm	Edgar Link	pending
R77.xml	Edgar Link	unprocessable
R78.htm	Edgar Link	pending
R78.xml	Edgar Link	unprocessable
R79.htm	Edgar Link	pending
R79.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R80.htm	Edgar Link	pending
R80.xml	Edgar Link	unprocessable
R81.htm	Edgar Link	pending
R81.xml	Edgar Link	unprocessable
R82.htm	Edgar Link	pending
R82.xml	Edgar Link	unprocessable
R83.htm	Edgar Link	pending
R83.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2013 Q3 Form 10-Q Financial Statement

#000072312513000108 Filed on July 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2013 Q3 Form 10-Q Financial Statement

#000072312513000108 Filed on July 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu